Aethlon Medical Inc (AEMD) SEC Filing 8-K Material Event for the period ending Monday, November 27, 2017

Aethlon Medical Inc

CIK: 882291 Ticker: AEMD

View differences made from one to another to evaluate Aethlon Medical Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aethlon Medical Inc.


Assess how Aethlon Medical Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aethlon Medical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: AEMD
CIK: 882291
Form Type: 8-K Corporate News
Accession Number: 0001683168-17-003164
Submitted to the SEC: Wed Nov 29 2017 8:30:10 AM EST
Accepted by the SEC: Wed Nov 29 2017
Period: Monday, November 27, 2017
Industry: Laboratory Analytical Instruments
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: